Boeing

Boeing's Q1 2026 results, reported April 22, showed revenue up 14% year-over-year to $22.2 billion, beating analyst expectations. All three business segments grew simultaneously for the first time in years.

EPS came in at -$0.20, significantly ahead of the consensus estimate of -$0.66, a 70% positive surprise that sent shares sharply higher in pre-market trading.

Commercial Airplanes delivered 143 aircraft in the quarter — 114 737s and 15 787s — as 737 production stabilized at 42 per month, with management targeting 47 per month by summer 2026.

Boeing guided for positive free cash flow of $1.0–$3.0 billion for full-year 2026, with improvement expected through Q2 onward as deliveries and production rates increase.

In May 2026, Boeing received orders for 109 aircraft from undisclosed customers, including 52 737 MAX jets, 28 777X widebodies, and 29 787 Dreamliners — a signal that demand remains robust despite the challenging prior years.

China re-engagement has become a material catalyst: President Xi Jinping committed to purchasing 200 Boeing 737s, a geopolitical thaw that reopens a market that had been effectively closed during tariff tensions.

Boeing completed its acquisition integration of Spirit AeroSystems, with Spirit contributing approximately $150 million in quarterly sales; the deal is expected to improve fuselage quality control on 737 production, though Spirit carries roughly $1 billion negative cash flow annually.

The MQ-25A Stingray drone was cleared for low-rate initial production in April 2026, advancing Boeing's autonomous aircraft capabilities within the Defense segment.

Bulls point to the turnaround narrative gaining traction: production rates are climbing, Q1 delivered the first simultaneous three-segment growth in years, debt was reduced by $6.9 billion in Q1, and forward free cash flow estimates imply a major recovery by 2028.

Bears remain focused on execution risk and legacy liabilities: the Spirit AeroSystems integration carries a $1 billion annual cash drag, the 737 MAX ramp has disappointed before, and the balance sheet remains heavily leveraged after years of losses and crises.

The China wildcard is central to the bull case — 200 committed 737s represent significant backlog upside — but geopolitical volatility means those deliveries are not guaranteed, and any re-escalation in trade tensions could remove them from near-term revenue.

Analyst consensus sits firmly at Buy, though the debate is about timing: most expect the recovery, but disagree on whether the current valuation already prices in successful execution or leaves room for upside if Boeing hits its production targets ahead of schedule.